- Home
- THAR vs LICN Comparison
THAR vs LICN Comparison
Compare THAR & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- LICN
- Stock Information
- Founded
- THAR 2017
- LICN 2004
- Country
- THAR United States
- LICN China
- Employees
- THAR N/A
- LICN N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- LICN
- Sector
- THAR Health Care
- LICN
- Exchange
- THAR Nasdaq
- LICN Nasdaq
- Market Cap
- THAR 2.4M
- LICN 2.1M
- IPO Year
- THAR 2022
- LICN 2023
- Fundamental
- Price
- THAR $1.20
- LICN $3.83
- Analyst Decision
- THAR Strong Buy
- LICN
- Analyst Count
- THAR 1
- LICN 0
- Target Price
- THAR $17.00
- LICN N/A
- AVG Volume (30 Days)
- THAR 97.3K
- LICN 87.9K
- Earning Date
- THAR 05-08-2025
- LICN 01-01-0001
- Dividend Yield
- THAR N/A
- LICN N/A
- EPS Growth
- THAR N/A
- LICN 36.90
- EPS
- THAR N/A
- LICN 55.10
- Revenue
- THAR N/A
- LICN $41,929,000.00
- Revenue This Year
- THAR N/A
- LICN N/A
- Revenue Next Year
- THAR N/A
- LICN N/A
- P/E Ratio
- THAR N/A
- LICN $0.06
- Revenue Growth
- THAR N/A
- LICN 24.86
- 52 Week Low
- THAR $0.95
- LICN $0.04
- 52 Week High
- THAR $6.45
- LICN $7.55
- Technical
- Relative Strength Index (RSI)
- THAR 43.85
- LICN 55.91
- Support Level
- THAR $1.05
- LICN $2.60
- Resistance Level
- THAR $1.28
- LICN $3.70
- Average True Range (ATR)
- THAR 0.11
- LICN 0.47
- MACD
- THAR 0.02
- LICN -0.02
- Stochastic Oscillator
- THAR 75.58
- LICN 61.50
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About LICN Lichen China Limited
Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.